These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

985 related items for PubMed ID: 8298644

  • 1. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ, Haber DA.
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [Abstract] [Full Text] [Related]

  • 2. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K, Fleming S.
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [Abstract] [Full Text] [Related]

  • 3. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M, König A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F.
    Hum Mutat; 1994 Dec; 3(3):212-22. PubMed ID: 8019557
    [Abstract] [Full Text] [Related]

  • 4. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK, Brown KW, Berry PJ.
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE.
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [Abstract] [Full Text] [Related]

  • 7. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA, Buckler AJ.
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [Abstract] [Full Text] [Related]

  • 8. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.
    Ramani P, Cowell JK.
    J Pathol; 1996 Jun; 179(2):162-8. PubMed ID: 8758208
    [Abstract] [Full Text] [Related]

  • 9. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, Szymik-Kantorowicz S, Daszkiewicz P, Debiec-Rychter M.
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [Abstract] [Full Text] [Related]

  • 10. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
    Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ, Reeve AE.
    Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
    [Abstract] [Full Text] [Related]

  • 11. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
    Mizuno K, Hayashi Y, Tozawa K, Iwatsuki S, Kojima Y, Kohri K.
    Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
    [Abstract] [Full Text] [Related]

  • 12. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ.
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [Abstract] [Full Text] [Related]

  • 13. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR, Yun K, Reeve AE, Eccles MR.
    Oncogene; 1995 Apr 20; 10(8):1677-81. PubMed ID: 7731725
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P, Telzerow P, Moksness J, Breslow NE.
    Med Pediatr Oncol; 1996 Nov 20; 27(5):429-33. PubMed ID: 8926924
    [Abstract] [Full Text] [Related]

  • 15. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN, Haber DA.
    Nat Rev Cancer; 2005 Sep 20; 5(9):699-712. PubMed ID: 16110318
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic rests and renal abnormalities in Brachmann-de Lange syndrome.
    Charles AK, Porter HJ, Sams V, Lunt P.
    Pediatr Pathol Lab Med; 1997 Sep 20; 17(2):209-19. PubMed ID: 9086528
    [Abstract] [Full Text] [Related]

  • 17. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
    Malkin D, Sexsmith E, Yeger H, Williams BR, Coppes MJ.
    Cancer Res; 1994 Apr 15; 54(8):2077-9. PubMed ID: 8174107
    [Abstract] [Full Text] [Related]

  • 18. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S, Tomlinson G, Nisen P, Haber DA.
    Cancer Res; 1993 Oct 15; 53(20):4757-60. PubMed ID: 8402654
    [Abstract] [Full Text] [Related]

  • 19. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
    Sakamoto J, Takata A, Fukuzawa R, Kikuchi H, Sugiyama M, Kanamori Y, Hashizume K, Hata JI.
    Pediatr Res; 2001 Sep 15; 50(3):337-44. PubMed ID: 11518820
    [Abstract] [Full Text] [Related]

  • 20. Wilms' tumour as a paradigm for the relationship of cancer to development.
    Pritchard-Jones K, Hastie ND.
    Cancer Surv; 1990 Sep 15; 9(3):555-78. PubMed ID: 1966278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.